IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 21 May 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00046-07v1
75/8/3729    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chakrabarty, K.
Right arrow Articles by Metcalf, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chakrabarty, K.
Right arrow Articles by Metcalf, J. P.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00046-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Human Lung Innate Immune Response to Bacillus anthracis Spore Infection

Kaushik Chakrabarty, Wenxin Wu, J. Leland Booth, Elizabeth S. Duggan, Nancy N. Nagle, K. Mark Coggeshall, and Jordan P. Metcalf*

Pulmonary and Critical Care Division, Department of Medicine, and Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, and Programs in Immunology and Cancer, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104

* To whom correspondence should be addressed. Email: jordan-metcalf{at}ouhsc.edu.


   Abstract

Bacillus anthracis, the causative agent of inhalational anthrax, enters a host through the pulmonary system before dissemination. We have previously shown that human alveolar macrophages participate in the initial innate immune response to B. anthracis spores through cell signal-mediated cytokine release. We proposed that the lung epithelia also participate in the innate immune response to this pathogen, and we have developed a human lung slice model to study this process. Exposure of our model to Bacillus anthracis (Sterne) spores rapidly activated the mitogen activated protein kinase signaling (MAPK) pathways ERK, p38, and JNK. In addition, RNase protection assay showed induction of mRNA of several cytokines and chemokines. This finding was reflected at the translational level with a protein peak fold increase of 3, 25, 9, 34, and 5, of IL-6, TNF-{alpha}, IL-8, MIP-1 {alpha}/{beta} and MCP-1 respectively, as determined by ELISA. Inhibition of individual pathways by UO126, SP600125, and SB0203580 decreased induction of chemokines and cytokines by spores, but this depended on the pathways inhibited and the cytokines and chemokines induced. Combining all three inhibitors reduced induction of all cytokines and chemokines tested to background levels. Immunohistochemistry for IL-6 and IL-8 revealed that alveolar epithelial cells and macrophages, and a few interstitial cells are the source of the cytokines and chemokines. Taken together, these data showed activation of pulmonary epithelium in response to Bacillus anthracis spore exposure. Thus, the lung epithelia actively participate in the innate immune response to Bacillus anthracis infection through cell signal-mediated elaboration of cytokines and chemokines.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.